# Session Log: FHIR-25063

**Phase:** prepared
**Work Group:** ClinicalInteroperabilityCouncil
**Source File:** `prepared/ClinicalInteroperabilityCouncil/FHIR-25063.md`

---

## Session Information

| Field | Value |
|-------|-------|
| **Session ID** | `f87a5def-b7e0-4b3b-ae40-d0467cd19b74` |
| **Session Summary** | Continue Preparing Tickets |
| **Agent ID** | `prep-FHIR-25063` |
| **Agent Type** | general-purpose |
| **Model** | claude-opus-4.6-1m |
| **Task Started** | 2026-04-09 19:23:46 UTC |
| **Duration** | 86s |
| **Total Tool Calls** | 12 |
| **Total Tokens** | 219,358 |

---

## Task Prompt

````markdown
You are preparing a FHIR Jira ticket for workgroup review.

## Ticket: FHIR-25063
## Work Group: Clinical Interoperability Council
## Output File: C:\ai\git\fhir-augury-content\prepared\ClinicalInteroperabilityCouncil\FHIR-25063.md

## Data Access
Use FhirAugury MCP tools (preferred) or fhir-augury CLI (fallback).

## Step 1: Gather Ticket and Cross-References (run in parallel)
- FhirAugury-get_item(source="jira", id="FHIR-25063", includeComments=true, includeContent=true, includeSnapshot=true)
- FhirAugury-cross_referenced(value="FHIR-25063", limit=50)

## Step 2-4: Fetch related Jira tickets, Zulip conversations (also search: FhirAugury-content_search(values="FHIR-25063", sources="zulip", limit=10)), and note GitHub items.

## Step 5: Build the Report using the standard ticket review structure.

## Rules - Use ONLY data from MCP/CLI. Do not fabricate. Be specific in dispositions. The recommendation must pick one.

## Final Step
Save to: C:\ai\git\fhir-augury-content\prepared\ClinicalInteroperabilityCouncil\FHIR-25063.md
````

---

## Agent Execution Log

### Turn 1

<details>
<summary>`FhirAugury-get_item`</summary>

**Arguments:**
```json
{
  "source": "jira",
  "id": "FHIR-25063",
  "includeComments": true,
  "includeContent": true,
  "includeSnapshot": true
}
```

**Result:**
```
# [jira] FHIR-25063: Clarify provenance - BC #11

- **status:** Triaged
- **type:** Change Request
- **priority:** Medium
- **work_group:** Clinical Interoperability Council
- **specification:** US Breast Cancer Radiology Reporting (FHIR)
- **resolution:** Persuasive
- **assignee:** Kurt Allen
- **reporter:** Gary Dickinson
- **labels:** A
- **Created:** 2019-10-28T21:09:55+00:00
- **Updated:** 2021-03-23T20:23:44+00:00
- **URL:** https://jira.hl7.org/browse/FHIR-25063

## Content
<p>Comment:</p>

<p>         Not clear if/how provenance is represented in this FHIR Implementation Guide.  Provenance (who, what, when, where, why) is essential at:  1) point of origination (at the source, for newly captured content), 2) point of update (for newly updated content, preserving previous content and its provenance).</p>



<p>         Who = subject of care/information (typically the patient)</p>

<p>         Who = performer of action taken</p>

<p>         Who = author of information captured or updated</p>

<p>         Who = organization</p>

<p>         What = action taken</p>

<p>         When = date/time of action taken</p>

<p>         When = date/time of information capture or update</p>

<p>         Where = physical location of action taken</p>

<p>         Where = physical location of information capture or update</p>

<p>         Where = network address and/or device ID where information captured or updated</p>

<p>         Why = rationale, purpose of action taken</p>

<p>         Why = rationale, purpose of information capture or update</p>



<p>         Granularity of provenance (e.g., binding authorship to content) may be at the dataset or element level.</p>

<p>         Summary:</p>

<p>         Clarify provenance</p>

## Snapshot
# FHIR-25063: Clarify provenance - BC #11

**Status:** Triaged  
**Type:** Change Request  
**Priority:** Medium  
**Resolution:** Persuasive  
**Assignee:** Kurt Allen  
**Reporter:** Gary Dickinson  
**Work Group:** Clinical Interoperability Council  
**Specification:** US Breast Cancer Radiology Reporting (FHIR)  
**Labels:** A  
**Created:** 2019-10-28  
**Updated:** 2021-03-23  
**Resolved:** 2019-11-06  

## Description

<p>Comment:</p>

<p>         Not clear if/how provenance is represented in this FHIR Implementation Guide.  Provenance (who, what, when, where, why) is essential at:  1) point of origination (at the source, for newly captured content), 2) point of update (for newly updated content, preserving previous content and its provenance).</p>



<p>         Who = subject of care/information (typically the patient)</p>

<p>         Who = performer of action taken</p>

<p>         Who = author of information captured or updated</p>

<p>         Who = organization</p>

<p>         What = action taken</p>

<p>         When = date/time of action taken</p>

<p>         When = date/time of information capture or update</p>

<p>         Where = physical location of action taken</p>

<p>         Where = physical location of information capture or update</p>

<p>         Where = network address and/or device ID where information captured or updated</p>

<p>         Why = rationale, purpose of action taken</p>

<p>         Why = rationale, purpose of information capture or update</p>



<p>         Granularity of provenance (e.g., binding authorship to content) may be at the dataset or element level.</p>

<p>         Summary:</p>

<p>         Clarify provenance</p>

## Resolution Description

<p>We agree that these elements are not well defined in this ballot, and intend to define them more thoroughly in the next ballot.</p>



```

</details>

<details>
<summary>`FhirAugury-cross_referenced`</summary>

**Result:**
```
No cross-referenced references found for "FHIR-25063".
```

</details>

<details>
<summary>`FhirAugury-content_search`</summary>

**Result:**
```
No results found.
```

</details>

### Turn 2

<details>
<summary>`create` — create a new file at C:\ai\git\fhir-augury-content\prepared\ClinicalInteroperabilityCouncil\FHIR-25063.md.</summary>

**Arguments:**
```json
{
  "path": "C:\\ai\\git\\fhir-augury-content\\prepared\\ClinicalInteroperabilityCouncil\\FHIR-25063.md",
  "file_text": "# FHIR-25063: Clarify provenance - BC #11\n\n## Summary\n\n| Field | Value |\n|-------|-------|\n| **Ticket** | [FHIR-25063](https://jira.hl7.org/browse/FHIR-25063) |\n| **Status** | Triaged |\n| **Type** | Change Request |\n| **Priority** | Medium |\n| **Resolution** | Persuasive |\n| **Work Group** | Clinical Interoperability Council |\n| **Specification** | US Breast Cancer Radiology Reporting (FHIR) |\n| **Reporter** | Gary Dickinson |\n| **Assignee** | Kurt Allen |\n| **Labels** | A |\n| **Created** | 2019-10-28 |\n| **Updated** | 2021-03-23 |\n| **Resolved** | 2019-11-06 |\n\n## Description\n\nThe ballot commenter (Gary Dickinson) notes that it is not clear if or how provenance is represented in the US Breast Cancer Radiology Reporting FHIR Implementation Guide. The comment argues that provenance \u2014 who, what, when, where, why \u2014 is essential at two key capture points:\n\n1. **Point of origination** \u2014 at the source, for newly captured content\n2. **Point of update** \u2014 for newly updated content, while preserving previous content and its provenance\n\nThe comment enumerates specific provenance dimensions:\n\n- **Who**: subject of care (patient), performer, author, organization\n- **What**: action taken\n- **When**: date/time of action, date/time of information capture or update\n- **Where**: physical location of action, physical location of capture/update, network address / device ID\n- **Why**: rationale or purpose of action, rationale or purpose of capture/update\n\nThe comment also notes that provenance granularity (e.g., binding authorship to content) may be at the dataset or element level.\n\n## Resolution Description\n\n> We agree that these elements are not well defined in this ballot, and intend to define them more thoroughly in the next ballot.\n\nThe work group agreed with the commenter that provenance elements were inadequately defined and committed to addressing them in a subsequent ballot cycle.\n\n## Keywords\n\nprovenance, who-what-when-where-why, authorship, origination, capture, update, granularity, Breast Cancer Radiology Reporting, ballot comment\n\n## Related Jira Tickets\n\nThis is one of a series of nearly identical provenance-related ballot comments filed by Gary Dickinson across multiple FHIR Implementation Guides. The comment text is substantially the same in each case:\n\n| Ticket | Title | Specification | Resolution | Status |\n|--------|-------|---------------|------------|--------|\n| [FHIR-24590](https://jira.hl7.org/browse/FHIR-24590) | How is provenance represented? - PCDE #13 | US Da Vinci PCDE (FHIR) | Persuasive with Modification | Applied |\n| [FHIR-24431](https://jira.hl7.org/browse/FHIR-24431) | Not clear if/how provenance is represented - PAS #253 | US Da Vinci PAS (FHIR) | Not Persuasive | Resolved - No Change |\n| [FHIR-24457](https://jira.hl7.org/browse/FHIR-24457

... *(truncated, 8449 chars total)*
```

**Result:**
```
Created file C:\ai\git\fhir-augury-content\prepared\ClinicalInteroperabilityCouncil\FHIR-25063.md with 8278 characters
```

</details>

